Keyphrases
Colorectal Cancer
86%
African American
86%
Elevated Microsatellite Alteration at Selected Tetranucleotide Repeats (EMAST)
81%
Microsatellite Instability-high (MSI-H)
61%
Immune Profile
61%
Tumor
52%
Low Prevalence
40%
Cancer Study
40%
Colon Cancer
34%
Immune Cells
34%
Racial Differences
34%
High Prevalence
34%
North Carolina
34%
Tumor Inflammation
20%
Survival Prognostication
20%
Population-based Cohort
20%
Acquired Defects
20%
Tetranucleotide Microsatellite
20%
Adenoma-carcinoma Sequence
20%
Immune Cell Profile
20%
Deficient Mismatch Repair (dMMR)
20%
Cancer Families
20%
Colorectal Tumor
20%
Family Registry
20%
Mismatch Repair Proteins
20%
Tumor-infiltrating Immune Cells
20%
Young Age
17%
Mismatch Repair
17%
High Mortality
17%
Common Disease
17%
Repeat Instability
17%
Racial Groups
17%
Adverse Outcomes
17%
Immune System
17%
Loss of Expression
17%
Genomic Instability
17%
Cell-Associated
17%
Advanced Stage
17%
Medicine and Dentistry
Colorectal Cancer
86%
Neoplasm
86%
Microsatellite Instability
61%
Immunocompetent Cell
52%
Biological Marker
52%
Prevalence
52%
DNA Mismatch Repair
40%
Race Difference
34%
Colon Cancer
34%
Mismatch Repair Protein
20%
Carcinoma
20%
Colorectal Tumor
20%
Immune Cell Infiltration
20%
Adenoma
20%
Prognostication
17%
Racial Group
17%
Genomic Instability
17%
Immune System
17%
Rectum Cancer
17%
Adverse Outcome
17%
Disease
17%
Malignant Neoplasm
17%
Immunology and Microbiology
Microsatellite Instability
100%
Prevalence
86%
Immunocompetent Cell
86%
Race Difference
57%
Colon
57%
Mismatch Repair
57%
Immune Cell Infiltration
33%
Genomic Instability
28%
Mismatch DNA Repair
28%
Immune System
28%